Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
SR
SRX Global Inc
SRXH
Mkt Cap
$23.8M
Volume
343.97K
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
SR
SRXH
SR
SRX Global Inc
SRXH
News
·
SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies
Mkt Cap
$24.1M
Volume
343.97K
Next Earnings
N/A
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies
SRX Global Inc. announced a definitive agreement to acquire CERo Therapeutics Holdings, Inc., an innovative cellular immunotherapy company developing CER-1236 for hematologic malignancies. The acquisition will be structured through a wholly-owned SPV (CERO 1236) to avoid diluting existing SRX shareholders. The transaction is expected to accelerate CER-1236's clinical development and provide CERo with enhanced access to capital and operational resources. CERo has treated six patients in its Phase 1 CERTAIN-T trial with no dose-limiting toxicities observed at increased dose levels.
GlobeNewswire Inc. · Oct 7, 2026
SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets
SRx Health Solutions has completed its acquisition of EMJ Crypto Technologies (EMJX) and rebranded as SRX Global Inc. The company is launching an AI-driven platform strategy focused on capital allocation into high-conviction operating companies and assets. The merged entity will be led by Kent Cunningham as CEO and Eric Jackson as President and Head of Asset Management, with initial investments in companies including Astro Capital, Opendoor Technologies, Uber Technologies, and Optimi Health Corp.
Benzinga · Jun 18, 2026
SRx Health Solutions Acquires 4.99% of Smartkem, Inc. (NASDAQ: SMTK)
SRx Health Solutions (NYSE: SRXH) has acquired a 4.99% stake in Smartkem, Inc. (NASDAQ: SMTK), a leader in advanced materials, through a shelf take down. The company also purchased convertible preferred securities in a non-brokered private placement. This acquisition comes as SRx Health Solutions is in the process of merging with EMJ Crypto Technologies (EMJX).
Benzinga · Jun 8, 2026
SRx Health Solutions Announces Board Approval to Dividend 75% of Profits from Investment in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies
SRx Health Solutions' board approved a plan to dividend 75% of profits from its investment in Astro Investment XVII, a special purpose vehicle with stakes in SpaceX and AI/space companies. The company, which is merging with EMJ Crypto Technologies, invested over 10% of its investable capital in the SPV and will return capital to shareholders upon wind down.
Benzinga · May 15, 2026
SRx Health Solutions Acquires Shares of Compass Inc. and Increases Investment in Opendoor Technologies Inc.
SRx Health Solutions (SRXH) announced the acquisition of shares in Compass Inc. and increased its investment in Opendoor Technologies Inc. The company also filed a Form S-4 with the SEC regarding its proposed merger with EMJ Crypto Technologies (EMJX). SRXH reported approximately 3.5% gains in its hedging pool and 8% gains in long treasury investments through mid-April.
Benzinga · Apr 16, 2026
SRx Health Solutions Returns +5.69% in March 2026 Driven by EMJX Artificial Intelligence (AI) Engine
SRx Health Solutions achieved a +5.69% return in March 2026 through its EMJX AI engine, significantly outperforming the S&P 500's -4.98% decline. The company's Board of Directors is considering implementing a quarterly dividend policy based on a percentage of profits from its investment portfolio.
Benzinga · Apr 7, 2026
SRx Health Solutions Hedges Decentralized Finance (DeFi) Portfolio with Investment in Gold and Reduces its Emerging Market Hedge
SRx Health Solutions announced it is hedging its decentralized finance (DeFi) portfolio by investing in gold while reducing its emerging market hedge. The company is preparing for the closing of its merger with EMJ Crypto Technologies (EMJX), a digital-asset treasury operating platform.
Benzinga · Mar 25, 2026
SRx Health Solutions Hedges Investments in Cryptocurrency and Emerging Markets for Volatility Protection
SRx Health Solutions (SRXH) announced it has entered into a hedged position on its cryptocurrency and emerging markets investment portfolio to protect against volatility. The company is in a definitive merger agreement with EMJ Crypto Technologies (EMJX) and expects to provide updates on the transaction timeline soon.
Benzinga · Mar 18, 2026
SRx Health Solutions Hedges Investments in Cryptocurrency and Emerging Markets for Volatility Protection
SRx Health Solutions announced it has entered into a hedged position on its cryptocurrency and emerging markets investment portfolio to protect against volatility. The company also provided an update on its pending merger with EMJ Crypto Technologies, stating it will provide shareholders with a timeline for closing the transaction in the near term.
GlobeNewswire Inc. · Mar 18, 2026
SRx Health Solutions Increases Ownership of Opendoor Technologies by 30% and is Now Net Long Cryptocurrency Holdings
SRx Health Solutions increased its ownership stake in Opendoor Technologies by 30% and reduced its cryptocurrency short positions across Bitcoin and Ethereum to become net long. The company also announced receiving a warning letter from NYSE American and reported Q1 2026 results while executing a definitive agreement to acquire EMJ Crypto Technologies.
GlobeNewswire Inc. · Feb 20, 2026
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
SR
SRXH
SRX Global Inc
Buy
Sell
Market
Limit
Soon
SRXH
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any SRXH yet.
Related Tickers
Earnings
Dividends
Last · Jul 22
Amount
$0.0500
Yield
4.20%
Annual
$0.0500